Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000601144 | SCV000726476 | likely benign | not specified | 2018-01-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000733045 | SCV000861061 | uncertain significance | not provided | 2018-05-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005091710 | SCV001057001 | likely benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002531618 | SCV003543459 | likely benign | Inborn genetic diseases | 2021-10-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |